Showing results (581-590 of 667) with videos related to

Sort By:
Pageof 67
Leukemia Research|April 23, 2019
Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysisBrett Stevens, Amanda Winters, Jonathan A Gutman, et al.
Nature Cancer|April 22, 2021
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cellsBrett M Stevens, Courtney L Jones, Daniel A Pollyea, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Targeting IL-1/IRAK1/4 signaling in Acute Myeloid Leukemia Stem Cells Following Treatment and RelapseTzu-Chieh Ho, Mark W LaMere, Hiroki Kawano, et al.
Neurology|November 4, 2022
Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRIK Ina Ly, Vanessa L Merker, Wenli Cai, et al.
Cell Metabolism|January 30, 2026
Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS-driven AMLAng Jia, Xiaowen Zhang, Ji-Hao Zhou, et al.
Blood|July 17, 2016
Evolution of acute myelogenous leukemia stem cell properties after treatment and progressionTzu-Chieh Ho, Mark LaMere, Brett M Stevens, et al.
Nature Medicine|November 8, 2016
Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infectionJoseph P Zackular, Jessica L Moore, Ashley T Jordan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trialsWendy A Woodward, Robert G Bristow, Michael F Clarke, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemiaMark A Gregory, Angelo D'Alessandro, Francesca Alvarez-Calderon, et al.
Nature Medicine|November 14, 2018
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemiaDaniel A Pollyea, Brett M Stevens, Courtney L Jones, et al.
Pageof 67